Compare SELF & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SELF | BTMD |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.8M | 72.7M |
| IPO Year | 1997 | 2021 |
| Metric | SELF | BTMD |
|---|---|---|
| Price | $5.16 | $2.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $6.00 | $2.83 |
| AVG Volume (30 Days) | 18.3K | ★ 183.1K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.25% | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | 0.04 | ★ 0.06 |
| Revenue | $12,705,245.00 | ★ $192,219,000.00 |
| Revenue This Year | $3.04 | $2.03 |
| Revenue Next Year | $3.47 | $6.58 |
| P/E Ratio | $129.60 | ★ $34.50 |
| Revenue Growth | ★ 1.40 | N/A |
| 52 Week Low | $4.73 | $1.27 |
| 52 Week High | $5.83 | $4.75 |
| Indicator | SELF | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 48.02 |
| Support Level | $4.93 | $1.35 |
| Resistance Level | $5.21 | $2.79 |
| Average True Range (ATR) | 0.09 | 0.15 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 22.30 | 35.23 |
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.